Harris Rotman has recently joined Madrigal Pharmaceuticals as the Senior Vice President, Global Regulatory Affairs. Harris brings twenty-five years of experience to regulatory affairs, including a track record in global, pre- and post-marketing regulatory affairs in pharma and biotech. Harris obtained his Ph.D. at Thomas Jefferson University and conducted post-doctoral work at Hahneman University prior to joining Wyeth in their Regulatory department. For the past twenty-five years he has held Regulatory positions of increasing responsibility at Shire, Sanofi, Indivior, Endo and SwanBio working in a number of therapeutic applications, pre- and post-marketing, US and ex-US. Prior to joining Madrigal, Harris was SVP Regulatory at Centessa Pharmaceuticals.